Table 1.
Number of samples (skin lesions) detected by quantitative PCR.
| Clinical form | Positive qPCR/total number (%) | qPCR positive/total number (%) |
||||||
|---|---|---|---|---|---|---|---|---|
| BI/H 0+ | BI/H 1+ | BI/H 2+ | BI/H 3+ | BI/H 4+ | BI/H 5+ | BI/H 6+ | ||
| TT | 21/38 (55.2) | 9/22 (40.9) | 12/16 (75) | – | – | – | – | – |
| BT | 20/21 (95.2) | – | 4/4 (100) | 12/13 (92.3) | 4/4 (100) | – | – | – |
| BB | 18/18 (100) | – | – | 2/2 (100) | 2/2 (100) | 6/6 (100) | 8/8 (100) | |
| BL | 12/12 (100) | – | – | – | – | – | 6/6 (100) | 6/6 (100) |
| LL | 13/13 (100) | – | – | – | – | – | – | 13/13 (100) |
| RR | 11/12 (91.7) | 2/3 (66.6) | 2/2 (100) | 1/1(100) | 1/1 (100) | 2/2 (100) | 3/3 (100) | – |
| ENL | 12/12 (100) | – | – | 4/4 (100) | 6/6 (100) | – | – | 2/2 (100) |
| Total | 107/126 (84.9) | 11/25 (44) | 18/22 (81.8) | 19/20 (95) | 13/13 (100) | 8/8 (100) | 17/17 (100) | 21/21 (100) |
qPCR, quantitative PCR; TT, tuberculoid; BT, borderline-tuberculoid; BB, borderline-borderline; BL, borderline-lepromatous; LL, lepromatous; RR, reversal reaction; ENL, erythema nodosum leprosum.
Distribution according to the clinical form and bacilloscopic index of histological sections (BI/H).